AGIO
Price
$34.41
Change
-$1.09 (-3.07%)
Updated
Jun 20 closing price
Capitalization
1.99B
40 days until earnings call
AXON
Price
$777.32
Change
+$6.53 (+0.85%)
Updated
Jun 20 closing price
Capitalization
60.51B
52 days until earnings call
Interact to see
Advertisement

AGIO vs AXON

Header iconAGIO vs AXON Comparison
Open Charts AGIO vs AXONBanner chart's image
Agios Pharmaceuticals
Price$34.41
Change-$1.09 (-3.07%)
Volume$1.67M
Capitalization1.99B
Axon Enterprise
Price$777.32
Change+$6.53 (+0.85%)
Volume$1.18M
Capitalization60.51B
AGIO vs AXON Comparison Chart in %
Loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGIO vs. AXON commentary
Jun 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a Hold and AXON is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 21, 2025
Stock price -- (AGIO: $34.41 vs. AXON: $777.32)
Brand notoriety: AGIO and AXON are both not notable
AGIO represents the Biotechnology, while AXON is part of the Aerospace & Defense industry
Current volume relative to the 65-day Moving Average: AGIO: 290% vs. AXON: 213%
Market capitalization -- AGIO: $1.99B vs. AXON: $60.51B
AGIO [@Biotechnology] is valued at $1.99B. AXON’s [@Aerospace & Defense] market capitalization is $60.51B. The market cap for tickers in the [@Biotechnology] industry ranges from $333.89B to $0. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $255.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B. The average market capitalization across the [@Aerospace & Defense] industry is $19.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 1 FA rating(s) are green whileAXON’s FA Score has 3 green FA rating(s).

  • AGIO’s FA Score: 1 green, 4 red.
  • AXON’s FA Score: 3 green, 2 red.
According to our system of comparison, AXON is a better buy in the long-term than AGIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 6 TA indicator(s) are bullish while AXON’s TA Score has 2 bullish TA indicator(s).

  • AGIO’s TA Score: 6 bullish, 4 bearish.
  • AXON’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, AGIO is a better buy in the short-term than AXON.

Price Growth

AGIO (@Biotechnology) experienced а +0.32% price change this week, while AXON (@Aerospace & Defense) price change was -0.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.70%. For the same industry, the average monthly price growth was +28.03%, and the average quarterly price growth was +14.56%.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +1.56%. For the same industry, the average monthly price growth was +12.40%, and the average quarterly price growth was +36.43%.

Reported Earning Dates

AGIO is expected to report earnings on Jul 31, 2025.

AXON is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+9.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Aerospace & Defense (+1.56% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($60.5B) has a higher market cap than AGIO($1.99B). AXON has higher P/E ratio than AGIO: AXON (187.31) vs AGIO (2.98). AXON YTD gains are higher at: 30.791 vs. AGIO (4.717). AXON has higher annual earnings (EBITDA): 398M vs. AGIO (-434.71M). AXON has more cash in the bank: 2.37B vs. AGIO (893M). AGIO has less debt than AXON: AGIO (52.9M) vs AXON (2.05B). AXON has higher revenues than AGIO: AXON (2.23B) vs AGIO (37M).
AGIOAXONAGIO / AXON
Capitalization1.99B60.5B3%
EBITDA-434.71M398M-109%
Gain YTD4.71730.79115%
P/E Ratio2.98187.312%
Revenue37M2.23B2%
Total Cash893M2.37B38%
Total Debt52.9M2.05B3%
FUNDAMENTALS RATINGS
AGIO vs AXON: Fundamental Ratings
AGIO
AXON
OUTLOOK RATING
1..100
1982
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
99
Overvalued
PROFIT vs RISK RATING
1..100
1006
SMR RATING
1..100
1754
PRICE GROWTH RATING
1..100
471
P/E GROWTH RATING
1..100
788
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AGIO's Valuation (42) in the Biotechnology industry is somewhat better than the same rating for AXON (99). This means that AGIO’s stock grew somewhat faster than AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (6) in the Biotechnology industry is significantly better than the same rating for AGIO (100). This means that AXON’s stock grew significantly faster than AGIO’s over the last 12 months.

AGIO's SMR Rating (17) in the Biotechnology industry is somewhat better than the same rating for AXON (54). This means that AGIO’s stock grew somewhat faster than AXON’s over the last 12 months.

AXON's Price Growth Rating (1) in the Biotechnology industry is somewhat better than the same rating for AGIO (47). This means that AXON’s stock grew somewhat faster than AGIO’s over the last 12 months.

AXON's P/E Growth Rating (8) in the Biotechnology industry is significantly better than the same rating for AGIO (78). This means that AXON’s stock grew significantly faster than AGIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGIOAXON
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
57%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 18 days ago
76%
Bullish Trend 16 days ago
78%
Declines
ODDS (%)
Bearish Trend about 1 month ago
77%
Bearish Trend 4 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
66%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCMCX28.18N/A
N/A
Goldman Sachs Mid Cap Value C
DASVX13.68N/A
N/A
Dunham Small Cap Value A
MFVFX13.88N/A
N/A
MassMutual Equity Opports R4
DIEMX40.17N/A
N/A
Driehaus Emerging Markets Growth Instl
AMPFX41.55-0.16
-0.38%
American Funds AMCAP F1